MUC5AC and glaucoma: Current treatment modalities for the treatment of ocular surface epithelial damage in patients suffering from such complications of anti-glaucoma eye drops consist of the instillation of non-preserved artificial tear drops, hyaluronic acid eye drops, or water and/or mucin secretagogues like 3% DQS or 2% rebamipide eye drops.